Gahl; William A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gahl; William A..The latest application filed is for "n-acetyl mannosammine as a therapeutic agent".

Company Profile

3.10.15

Gahl; William A. - Bethesda MD
Gahl; William A. - Kensington MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Cannabinoid receptor mediating compounds Grant 11,155,521 - Cinar , et al. October 26, 2	2021-10-26
N-acetyl mannosammine as a therapeutic agent Grant 10,953,026 - Huizing , et al. March 23, 2	2021-03-23
N-acetyl Mannosammine As A Therapeutic Agent App 20190374561 - Huizing; Marjan ; et al.	2019-12-12
N-acetyl mannosammine as a therapeutic agent Grant 10,335,426 - Huizing , et al.	2019-07-02
N-acetyl Mannosammine As A Therapeutic Agent App 20180117072 - Huizing; Marjan ; et al.	2018-05-03
Cannabinoid Receptor Mediating Compounds App 20160257654 - Cinar; Resat ; et al.	2016-09-08
Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation Grant 9,364,448 - Brooks , et al. June 14, 2	2016-06-14
Hyposialylation disorders Grant 9,341,619 - Huizing , et al. May 17, 2	2016-05-17
Hyposialylation Disorders App 20160025717 - Huizing; Marjan ; et al.	2016-01-28
N-acetyl Mannosammine As A Therapeutic Agent App 20150290229 - Huizing; Marjan ; et al.	2015-10-15
N-acetyl mannosamine as a therapeutic agent Grant 9,095,597 - Huizing , et al. August 4, 2	2015-08-04
Nitisinone For Treatment Of Oculocutaneous/ocular Albinism And For Increasing Pigmentation App 20140371325 - Brooks; Brian P. ; et al.	2014-12-18
Hyposialylation Disorders App 20140271615 - Huizing; Marjan ; et al.	2014-09-18
Nitisinone for treatment of oculocutaneous/ocular albinism and for increasing pigmentation Grant 8,822,540 - Brooks , et al. September 2, 2	2014-09-02
N-acetyl Mannosamine As A Therapeutic Agent App 20130196936 - Huizing; Marjan ; et al.	2013-08-01
Adenosine Receptor Agonists For The Treatment And Prevention Of Vascular Or Joint Capsule Calcification Disorders App 20130109645 - Gahl; William A. ; et al.	2013-05-02
N-acetyl mannosamine as a therapeutic agent Grant 8,410,063 - Huizing , et al. April 2, 2	2013-04-02
Encapsulated N-acetylmannosamine Or N-acetylneuraminic Acid To Increase Sialylation App 20130058998 - Huizing; Marjan ; et al.	2013-03-07
Nitisinone For Treatment Of Oculocutaneous/ocular Albinism And For Increasing Pigmentation App 20120322887 - Brooks; Brian P. ; et al.	2012-12-20
N-acetyl Mannosamine As A Therapeutic Agent App 20100249047 - Huizing; Marjan ; et al.	2010-09-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.